nnm-2021-0164 - Supplementary Figure 2
Supplementary Figure 2. Cotreatment with TMZ-BZP-LNC+ reduces the tumor size but presents toxic effects related to intranasal administration in the lungs. (A) Timeline of the experiment and therapeutic scheme employed (B) Tumor size quantification of implanted gliomas (C) Images of animal lungs. The values are represented as means ± S.D. of 4 animals per group. (*p<0.05 **p<0.01 significantly different from the CTRL).